Strategic challenges 2017-21

 

Our strategy 2017-21 sets out the following 5 strategic challenges

 

  1. To harness our expertise and convening power to tackle the biggest scientific and health challenges and opportunities facing our society.
  2. To lead innovation in the development of research talent through funding and careers support.
  3. To achieve influence and impact beyond the UK to improve health and well-being.
  4. To become the exemplar of a ‘modern scientific academy’ – diverse, trusted, dynamic, relevant and accessible.
  5. To enhance the Academy’s delivery capability, making sure we have the Fellows, staff, partners, resources and influence to make an even greater contribution to the UK and beyond.
 

 

Strategic challenge 1: To harness our expertise and convening power to tackle the biggest scientific and health challenges and opportunities facing our society.

 

We will achieve this by:

  1. Harnessing connections across research disciplines, sectors (academia, NHS, industry, charities, policymakers, media) and communities.
  2. Bringing Fellows, experts and stakeholders together through our working group studies, symposia and workshops to produce high quality debates and outputs that shape the policy and research agenda in the UK and beyond.
  3. Providing decision-makers in Government and elsewhere with timely and relevant evidence and advice.
  4. Maximising influence and impact through effective follow up and implementation of our recommendations.
  5. Establishing programmes of horizon-scanning and scientific meetings, where Fellows and experts discuss latest developments, identify opportunities and address scientific and health challenges.
  6. Growing the scale, visibility and impact of our FORUM network of organisations across industry, academia, healthcare, regulation and beyond, providing a unique platform for high-level, strategic interactions across these sectors.
  7. Influencing at the highest levels – alone and in partnership – to ensure that the UK has the resources, infrastructure and regulatory framework to optimise biomedical and health research outputs and impacts.
  8. Continuing to pioneer the incorporation of innovative patient, public and stakeholder dialogue into our policy activities, ensuring these views shape our recommendations and outputs.

Admissions Day 2017

Book Now

Strengthening clinical research capacity in low and middle income countries

Book Now

Looking to the future: endpoints in clinical research

Book Now
View more